Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Corynebacterium

ABSTRACT: Whole genome sequencing of Corynebacterium species

PROVIDER: PRJNA541849 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR12270031_1.fastq.gz	Fastqsanger.gz
	SRR12270031_2.fastq.gz	Fastqsanger.gz
	SRR12270032_1.fastq.gz	Fastqsanger.gz
	SRR12270032_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 623

Similar Datasets

Proteomic analysis of Corynebacterium pseudotuberculosis strain 12CS0282

Project description:The data set comprises results from the whole cellular proteome, secreted proteins and proteins located on the bacterial surface of Corynebacterium pseudotuberculosis. The theroretical proteome was created from genome analysis and characterized using bioinformatical analysis.

2022-11-21 | PXD036354 | Pride

Gene expression patterns of pediocin-producing Corynebacterium glutamicum strains

Project description:Strains: non-producing refernece strain pXMJ19 (CR099 pXMJ19; Goldbeck et al., 2021) and Pediocin-producer pxMJ19 ped (CR099 pXMJ19 Ptac pedACDCg, Goldbeck et al., 2021) Pediocin-producing and non-producing strains of Corynebacterium glutamicum were compared in a whole genome microarray analysis setup in order to identify potential strain optimization targets

2023-03-08 | GSE220713 | GEO

Corynebacterium striatum

Project description:Corynebacterium striatum whole genome sequencing

| PRJNA557067 | ENA

Corynebacterium

Project description:Corynebacterium species isolated from animals

| PRJNA681547 | ENA

Corynebacterium pseudotuberculosis C231

Project description:Corynebacterium pseudotuberculosis strain C231, whole genome sequencing

| PRJNA40875 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Corynebacterium afermentans

Project description:Whole genome sequencing of Corynebacterium afermentans, an opportunistic pathogen

| PRJDB2137 | ENA

Corynebacterium jeikeium

Project description:Whole genome sequencing of Corynebacterium jeikeium, an opportunistic pathogen

| PRJDB2029 | ENA

Corynebacterium striatum

Project description:Whole genome sequencing of Corynebacterium striatum, an opportunistic pathogen

| PRJDB2443 | ENA

Corynebacterium diphtheriae

Project description:Whole genome sequencing of Corynebacterium diphtheriae, an opportunistic pathogen